Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

766 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan.
Zhao T, Tani Y, Makino-Okamura C, Takita M, Yamamoto C, Kawahara E, Abe T, Sugiura S, Yoshimura H, Uchiyama T, Yamazaki I, Ishigame H, Ueno T, Okuma K, Wakui M, Fukuyama H, Tsubokura M. Zhao T, et al. Among authors: sugiura s. Front Immunol. 2024 Mar 18;15:1337520. doi: 10.3389/fimmu.2024.1337520. eCollection 2024. Front Immunol. 2024. PMID: 38562937 Free PMC article.
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.
Tani Y, Takita M, Kobashi Y, Wakui M, Zhao T, Yamamoto C, Saito H, Kawashima M, Sugiura S, Nishikawa Y, Omata F, Shimazu Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Kami M, Tsubokura M. Tani Y, et al. Among authors: sugiura s. Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920. Vaccines (Basel). 2023. PMID: 37243024 Free PMC article.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A, Takita M, Ito N, Kawashima M, Sugiura S, Shibuya K, Iwami S, Kim K, Iwanami S, Kodama T, Tsubokura M. Yoshida M, et al. Among authors: sugiura s. Vaccines (Basel). 2022 Mar 26;10(4):515. doi: 10.3390/vaccines10040515. Vaccines (Basel). 2022. PMID: 35455264 Free PMC article.
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey.
Kobashi Y, Kawamura T, Shimazu Y, Zhao T, Sugiyama A, Nakayama A, Kaneko Y, Nishikawa Y, Omata F, Takita M, Yamamoto C, Yoshida M, Kosaka M, Murayama A, Sugiura S, Tanaka M, Kawashima M, Uchi Y, Shindo J, Oikawa T, Shibuya K, Kodama T, Tsubokura M. Kobashi Y, et al. Among authors: sugiura s. Sci Rep. 2022 Nov 7;12(1):18929. doi: 10.1038/s41598-022-21797-x. Sci Rep. 2022. PMID: 36344597 Free PMC article.
Long-Term Outcomes After Slow Low-Dose Oral Immunotherapy for Cow's Milk.
Matsuo Y, Sugiura S, Masukane S, Tanaka F, Makino A, Kitamura K, Matsui T, Takasato Y, Ito K. Matsuo Y, et al. Among authors: sugiura s. Int Arch Allergy Immunol. 2024 Dec 11:1-20. doi: 10.1159/000542796. Online ahead of print. Int Arch Allergy Immunol. 2024. PMID: 39662061
766 results